AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4

Janumet XR CP Tablet

Prescription Icon
Prescription Required

Marketer

MSD Pharmaceuticals Pvt Ltd

Salt Composition

Sitagliptin (100mg) + Metformin (1000mg)

Overview Janumet XR CP Tablet

This dual-action medication, formulated as an extended-release tablet, effectively manages elevated blood glucose in individuals with type 2 diabetes. This dual approach helps mitigate the risk of severe diabetic complications like vision impairment and kidney disease, and may also lessen the probability of cardiovascular events. It can be used independently or in conjunction with other diabetes therapies, achieving optimal results when combined with a balanced diet and regular physical activity. Dosage is individualized, considering your health status, glucose levels, and other medications. Ingesting it with food minimizes gastrointestinal discomfort. Consistent daily intake at the same time is crucial for efficacy; discontinuation should only occur under your physician's guidance. Adherence to your prescribed diet and exercise plan is vital for successful diabetes management; lifestyle choices significantly impact blood sugar control. Commonly reported side effects include nausea, vomiting, diarrhea, stomach upset, headache, and throat irritation. Hypoglycemia is a potential risk, especially when used with insulin or sulfonylureas; learn to identify and manage this complication. This medication isn't appropriate for all patients. Prior to commencing treatment, inform your doctor of any history of kidney, liver, or heart disease, pancreatic issues, or significant alcohol consumption. Pregnant or lactating women require prior medical consultation. Interaction with other medications is possible; provide your doctor with a comprehensive list of all your current medications to ensure safety. Alcohol consumption should be minimized due to its potential to lower blood sugar. Your doctor will monitor your renal function and blood glucose levels throughout the treatment period.

Uses of Janumet XR CP Tablet

Managing type 2 diabetes

Major Benefits of Janumet XR CP Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Janumet XR CP Tablets should be administered with a meal.

Common Side effects of Janumet XR CP Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Janumet XR CP Tablet:

Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid crushing, chewing, or breaking it. Janumet XR CP Tablets should be administered with food.

How Janumet XR CP Tablet works:

Janumet XR CP tablets combine sitagliptin and metformin to manage blood sugar. Sitagliptin boosts insulin production by the pancreas, improves insulin utilization, and lessens hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. This dual action leads to improved glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Janumet XR CP Tablets is dangerous.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Janumet XR CP Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Janumet XR CP Tablets while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Impaired driving is a possibility if your blood glucose levels are abnormally low or elevated. Refrain from driving should such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Janumet XR CP tablets cautiously, potentially requiring dosage modification. Consult your physician for guidance. Janumet XR CP tablets are contraindicated in patients with severe kidney disease. Regular monitoring of renal function is recommended during treatment.

LiverLiverUNSAFE

Individuals with liver conditions should likely refrain from using Janumet XR CP Tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Janumet XR CP Tablet :

Should you forget a Janumet XR CP Tablet dose, take it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Janumet XR CP Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Janumet XR CP Tablet

Janumet XR CP Tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged Janumet XR CP Tablet use can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, supplemental vitamin B12 is sometimes recommended annually.
Janumet XR CP Tablets may cause common side effects such as hypoglycemia (low blood sugar), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infection. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Janumet XR CP Tablets are contraindicated in patients with allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Janumet XR CP Tablet and alcohol is unsafe due to the increased risk of lactic acidosis.
Store this medication in its original, tightly closed container, as directed on the label. Dispose of any unused medication properly and ensure it remains inaccessible to children, pets, and others.
Janumet XR CP Tablets can cause lactic acidosis, a serious medical emergency resulting from excess blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol, and is thus avoided in such individuals. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Janumet XR CP tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Janumet XR CP Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Janumet XR CP Tablets are contraindicated in patients with allergies to any ingredient or excipient. This medication should also be avoided in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Janumet XR CP tablets with alcohol is unsafe and may raise your risk of lactic acidosis.
Janumet XR CP Tablets can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as MALA, Metformin-associated lactic acidosis). This rare side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol, hence its avoidance in these groups. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged Janumet XR CP Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as numbness, tingling in extremities, weakness, and balance issues), urinary problems, and cognitive changes. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Janumet XR CP tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This combination is not suitable for individuals under 18.
Janumet XR CP Tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Janumet XR CP Tablets are contraindicated in patients with allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Janumet XR CP Tablet with alcohol is unsafe and may raise your risk of lactic acidosis.
Janumet XR CP Tablets can cause lactic acidosis, a serious medical emergency resulting from excess blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect is a reason to avoid metformin in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged Janumet XR CP Tablet use can lead to vitamin B12 deficiency by interfering with its stomach absorption. This deficiency may cause anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. Yearly supplemental vitamin B12 is recommended by some researchers to mitigate these risks.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Janumet XR CP Tablet
335